Ovarian Cancer (Vaccines)
Ovarex Granted Orphan Drug Status
Published in Women's Health Weekly, February 10th, 1997
The Ovarex vaccine, which has been undergoing Phase II/III clinical trials in Canada and Europe, is based on the concept of Anti-idiotype Induction Therapy (AIT) which allows the patient's own body to fight cancer through the enhancement of the body's immune system against the cancer cells. For a seven year period, orphan drug status provides a protected market for an approved product whereby no approval will be given to a subsequent sponsor of the same drug product for the same disease...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- AIDS/HIV (Conference Coverage)
UNAIDS Chief: Only a Vaccine Can End AIDS - Breast Cancer (Prognosis)
Human Cell Cycle Proteins Shown to be Excellent Prognostic Markers - Breast Cancer (Screening)
Connecticut Campaign Urges Poor Women to Get Mammograms - Cardiovascular Health (Prophylaxis)
FDA Urged to Expand Uses for Aspirin, Benefits for Women - Cardiovascular Health (Survey)
U.S. Women Dangerously Misinformed About Their Hearts - Contraceptives (Norplant)
Implant Has Second Highest Number of Complaints in FDA Report - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
